Electrochemical studies and square wave adsorptive stripping voltammetry of the antidepressant fluoxetine by Silva, A. M. S. Roque da et al.
Talanta 49 (1999) 611–617
Electrochemical studies and square wave adsorptive
stripping voltammetry of the antidepressant fluoxetine
A.M.S. Roque da Silva a, J.C. Lima a, M.T. Oliva Teles b,
A.M. Oliveira Brett c,*
a CEQUP:Departamento de Quı´mica-Fı´sica, Faculdade de Farma´cia, Uni6ersidade do Porto, R. Anı´bal Cunha, 164,
4050 Porto, Portugal
b Departamento de Eng. Quı´mica, Institute Superior de Engenharia do Porto, R. S. Tome´, 4000 Porto, Portugal
c Departamento de Quı´mica, Faculdade de Cieˆncias e Tecnologia, Uni6ersidade de Coimbra, 3049 Coimbra, Portugal
Received 29 September 1997; received in revised form 20 January 1999; accepted 26 January 1999
Abstract
The electrochemical reduction of the antidepressant drug fluoxetine was investigated by cyclic, linear sweep,
differential pulse and square wave voltammetry using a hanging mercury drop electrode in alkaline buffer solution in
water and in a water:acetonitrile mixed solvent. Cyclic voltammograms in aqueous solution showed very strong
adsorption of fluoxetine on the electrode with formation of a compact film. The effect of addition of different
percentages of acetonitrile on the voltammetric response was evaluated. It is shown that acetonitrile protects the
electrode surface, thus preventing the adsorption of fluoxetine as a compact film, although reduction occurs at more
negative potentials. Adsorption was used to accumulate the drug onto the electrode surface. The adsorbed species
were measured voltammetrically by reduction at 1.3 V in an aqueous 0.05 M Ringer buffer, pH 12, 20%
acetonitrile v:v. Linear calibration graphs were obtained in the range 0.52–5.2 M. The quantification of fluoxetine in
pharmacological formulations existing in the market was performed using adsorptive square wave cathodic stripping
voltammetry. and compared with data from UV spectrophotometry. The method is simple and not time-consuming.
A comparative high performance liquid chromatography assay with UV detection was performed. Recovery data for
both methods are reported. © 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
The continuous demand for anti-depressive
drugs with minimal side effects, mainly cardiovas-
cular accidents or anticholinergic activity, gave
rise to the development of the anti-depressant
* Corresponding author. Tel.: 351-39-835-295; fax: 
351-39-935-295.
E-mail address: brett@cygnus.ci.uc.pt (A.M. Oliveira Brett)
0039-9140:99:$ - see front matter © 1999 Elsevier Science B.V. All rights reserved.
PII: S0039 -9140 (99 )00050 -8
A.M.S. Roque da Sil6a et al. : Talanta 49 (1999) 611–617612
drug fluoxetine, N-methyl-8-14-(trifluoromethyl)
phenoxylbenzenepropanamine.
It works by inhibiting the uptake of serotonine by
the neurons in the brain, enhances serotonine
neurotransmission and has the longest half-life of
all the selective serotonine reuptake inhibitors
(SSRIs). It has been used for the treatment of
major depression, obsessive–compulsive disorder,
borderline personality and panic disorders, ner-
vous anorexia and bulimia, autism, obesity, alco-
holism, geriatrics, and deintoxication by cocaine
[1–5]. Fluoxetine is clinically administered orally
in the form of chlorhydrates and is the most
widely prescribed antidepressant in the USA. The
precise mechanism of action is not clear but it has
less sedative, anticholinergic and cardiovascular
effects than the tricyclic antidepressant drugs.
Fluoxetine is metabolized to norfluoxetine which
is also active. It is highly protein-bound and
readily crosses the blood–brain barrier and the
placenta, consequently also appearing distributed
into breast milk. Carcinogenic studies provided
evidence that fluoxetine is neither a complete car-
cinogen nor a tumor promoter [6].
The control of fluoxetine and norfluoxetine has
been accomplished in blood serum using gas chro-
matography [7–12] and, to a larger extent, by
high pressure liquid chromatography (HPLC)
with fluorescence or UV detection [13–24].
This paper is concerned with the study of the
adsorptive voltammetric behaviour of fluoxetine
using a hanging mercury drop electrode (HMDE)
in different buffer solutions. In the literature, no
references were found concerning the use of elec-
troanalytical techniques for the determination of
this substance or studies of the electron transfer
mechanisms of fluoxetine. Based on the results
obtained, a square wave adsorptive voltammetric
quantification method was developed. This proce-
dure was applied to the determination of fluox-
etine in commercial preparations existing in the
market and the results were compared with those
obtained by the same determination using HPLC
with UV detection.
2. Experimental
Fluoxetine chlorhydrate was kindly supplied by
the laboratory El Lilly Pharmaceuticals (Indiana-
polis, IN, USA). All the chemicals used were of
reagent grade quality and they were employed
without further purification. The most conclusive
experiments were performed in 0.05 M Ringer
buffer (HPO42:PO43) in the range pH 9–12, and
were prepared using purified water from a Mil-
lipore Milli-Q system.
The working electrode was a Metrohm multi-
mode HMDE, the counter electrode a carbon rod
and the reference electrode was AgCl:Ag:3 M
KCl, used in a one-compartment cell of a 663 VA
stand Metrohm. Voltammograms were recorded
using a Autolab PSTAT 10 potentiostat:galvanos-
tat running with model GPES version 3 software,
from Eco-Chemie, Netherlands. The potential
range studied was from 0.8 to 1.8 V vs.
Ag:AgCl, cyclic voltammetry scan rates varying
from 20 to 800 mV s1. Differential pulse voltam-
metry conditions were: pulse amplitude, 40 mV;
pulse width, 70 ms; scan rate, 6 mV s1; and
square wave voltammetry conditions were: pulse
amplitude, 40 mV; frequency, 50 Hz; potential
step, 6 mV.
The HPLC system used was a Sykan model A
1210 liquid chromatograph, equipped with a
model 3200 UV:Vis detector and connected to a
computing integrator model PRIME version 2.2.6
chromatography data station. For chromato-
graphic separation, a Technopak 10 C18 column
(2504 mm, 5 mM particle size) was employed.
The separation was carried out at room tempera-
ture using, as the mobile phase, 40% acetoni-
trile:60% 0.05 M potassium dihydrogenphosphate
(pH 4.7) filtered through a 0.45 mm filter and
degassed with a helium sparge. A Hamilton 50 ml
syringe was used for sample injection.
The pharmaceutical samples were prepared by
mixing and the content of 10 capsules followed by
weighing exactly around one-tenth of it. To this
powder aliquot was added 80 ml of water in a 100
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ml dilution flask. This was placed during 15 min
in an ultrasonic bath, before completing the vol-
ume up to 100 ml with water. This procedure was
repeated 10 times.
Adsorptive voltammetry measurements were
carried out in the square wave voltammetry mode
(SWV) under the following optimized conditions:
accumulation potential, 0.8 V and accumula-
tion time, 5 s, with stirring at 500 rpm. An
equilibrium time of 5 s was allowed to elapse
between the end of the stirring and the start of the
potential scan from 1.0 to 1.8 V. The ad-
sorptive cycle was repeated three times using a
new mercury drop each time, the result being
expressed as the average of the four measure-
ments. Quantification of fluoxetine was performed
by means of the standard addition method.
To calculate the recovery, another aliquot of
the powder sample was weighed and a known
number of milligrams of fluoxetine clorhydrate
were added; the quantification procedure already
described was carried out.
3. Results and discussion
The electrochemical reduction process of fluox-
etine at the HMDE leads to very strong adsorp-
tion on the electrode surface, as seen from the
cyclic voltammograms in Fig. 1, at pH 12. The
shape of the cyclic voltammograms suggests that,
in the conditions used, they correspond to a
quasi-reversible system for adsorbed species, since
there is only a very little separation of 10 mV
between anodic and cathodic peaks. The curve is
almost symmetric round Ep, the width at half-
height, W1:2, decreases slightly as the concentra-
tion increases, and the peak current is
proportional to the scan rate, n, for both the
anodic and the cathodic peaks. Also the peak
potential does not vary with scan rate, n, and the
oxidation peak only appears for very high scan
rates (Fig. 1b). However, the adsorption peak
height for the reduction does not vary linearly
with concentration, suggesting blocking by forma-
tion of a compact film on the electrode surface
[29–32].
The strong adsorption process taking place on
the electrode surface corresponding to the accu-
mulation of fluoxetine was confirmed by repetitive
cyclic voltammograms recorded after dipping the
HMDE in a stirred solution of the drug for a
period of 5 s at 0.8 V. The short accumulation
time gives substantial enhancement of the ca-
thodic peak (first scan) compared with those of
non-accumulated species (subsequent scans), thus
indicating a rapid desorption of fluoxetine from
the electrode surface.
The study of peak potential, Ep, versus pH, in
Britton Robinson buffer, showed that the reduc-
tion signal for fluoxetine appears only for pH
values higher than 8.5. This is because reduction
only occurs at very negative potentials, as is pre-
dicted for this type of compound [24,25]. Conse-
quently, the reduction peak can only be expected
to be observed when very high pH value support-
ing electrolytes are used because in those experi-
mental conditions, the negative potential range
for HMDE is increased up to 2.0 V vs. Ag:
AgCl, and the reduction peak can be recorded.
Fluoxetine molecules are potentially basic on ac-
count of the unshared electron pair of the oxygen
atom and at these pH values it is the unproto-
nated form that is reacting (Fig. 2). The peak
potential was only shifted slightly to more positive
values as the pH was increased, the slope corre-
sponds to 6.1 mV per unit of pH. Thus the
reduction of fluoxetine is pH independent.
The reduction reaction mechanism of fluoxetine
is quite general for aromatic compounds [25–28]
Fig. 1. Cyclic voltammograms of fluoxetine at scan rates of:
(a) 90 mV s1; (b) 600 mV s1. Concentrations: 6.36, 7.93,
9.50, 11.1 and 12.6 mM in 0.05 M Ringer buffer, pH 12,
tdep5s at Edep 0.8V.
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Fig. 2. Plot of Ep vs. pH for a 6.36 M fluoxetine solution in
0.05 M Ringer buffer solutions. The line corresponds to a
slope of 6.1 mV per unit of pH.
Fig. 3. Cyclic voltammograms of fluoxetine at 600 mV s1.
Concentrations: 1.46, 2.04 and 2.62 mM in 0.05 M Ringer
buffer, pH 12, tdep60 s at Edep 0.8 V.
shifted to more negative values and W1:2 de-
creased as the concentration or the accumulation
time was increased.
Quantitative determinations of fluoxetine were
very irreproducible due to the very strong adsorp-
tion causing decrease of peak height in successive
scans. When a buffer supporting electrolyte in an
acetonitrile:water mixed solvent was used, the re-
producibility of the peaks and the resolution of
the peaks improved although the peak potentials
were shifted 200 mV to more negative values.
Comparison between Fig. 4a and Fig. 4b shows
the effect of using 20% acetonitrile:80% water as
solvent.
and is considered to require the formation of a
radical anion formed by electron transfer into an
antibonding orbital of the arene linked to the
oxygen. The peak current increased until pH 10.5
and then became constant until pH 12.5. Since the
best definition of peaks was observed for pH 12 in
Ringer buffer, this supporting electrolyte was cho-
sen for subsequent experiments.
The strong adsorption process of fluoxetine on
the electrode surface depended on the accumula-
tion time and was investigated further. Without
accumulation, when the concentration was low-
ered to 1 mM, a negligible current was observed.
However, a well-defined peak was observed if a 60
s accumulation period preceded the potential
scan. For micromolar concentrations, besides the
adsorption peak, a diffusion peak, due to the
reduction of diffusing molecules, appears for a
long deposition time. Fig. 3 shows the diffusion
peak as a shoulder before the adsorption peak in
the negative potential scan [29]. A deposition
potential of 0.8 V was chosen and accumula-
tion times varying from 5 to 80 s were evaluated,
after which CVs were recorded. For concentra-
tions less than 1 M, 20 s deposition time led to the
maximum current. However, at higher concentra-
tions, the shape and peak height, in reduction as
in oxidation, shows the same behaviour as de-
scribed elsewhere [29–32] for the case of strong
adsorption with formation of a compact film on
the electrode surface. The peak potential was
Fig. 4. Adsorptive linear sweep voltammetry of fluoxetine, (a)
0.05 M Ringer buffer, pH 12; (b) 0.05 M Ringer buffer, pH 12,
20% acetonitrile v:v. Scan rate, 800 mV s1; concentrations:
0.92, 1.85, 2.76, 3.68 and 4.59 mM, tdep20 s at Edep 0.8
V.
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Fig. 5. Cyclic voltammogram of 12.5 mM fluoxetine in 0.05 M
Ringer buffer, pH 12, 20% acetonitrile v:v. Scan rate, 800 mV
s1; tdep20 s at Edep 0.8 V.
tions, the non-linear relationship between peak
current, ip, and n1:2 shows again that the reduc-
tion process is not only diffusion controlled, but
there is an important adsorption component.
In the presence of acetonitrile, different poten-
tial scan modes, i.e. linear sweep voltammetry
(LSV), differential pulse voltammetry (DPV) and
square wave voltammetry (SWV), were applied to
the stripping analysis of the adsorbed fluoxetine
(Fig. 6). It was found that the use of pulse tech-
niques improves the sensitivity, as expected. The
largest slope value in the plot of peak current vs.
concentration, 14.3 nA M1, was obtained using
SWV while values of 6.18 and 0.93 nA M1 were
achieved using LSV and DPV respectively. There-
fore, square wave voltammetry was chosen for
further work since this technique is less time
consuming and shows the best peak resolution.
For electroanalytical purposes, the optimised
conditions for square wave adsorptive stripping
voltammetry found were accumulation of fluox-
etine on the electrode surface during a total of 10
s at a potential of 0.8 V, 5 s with stirring at 500
rpm, followed by 5 s without stirring, supporting
electrolyte 0.05 M Ringer buffer, 20% of acetoni-
trile v:v, frequency 50 Hz, pulse amplitude 40 mV,
potential step 6 mV, and scan from 1.0 to
1.6 V.
According to Ref. [33], the differential capacity
of the electric double layer is a very sensitive
function of the adsorption of organic molecules at
the mercury electrode surface. At high positive
and negative surface charges, the adsorption–des-
orption peaks on the C vs. 8 curves, are very
much lower or vanish entirely in the case of
solution in organic solvents in comparison with
aqueous solutions. The influence of the mixture of
aqueous with organic electrolyte in the height and
position of the peaks on the C vs. 8 curves is
caused by the salting-out of the organic substance
[34], giving rise to a shift of the cathodic peak in
the negative direction and an increase of the peak
height. This is in good agreement with our exper-
iments where the shift of the peak potentials
200 mV to more negative potentials was
observed.
The influence of different percentages of ace-
tonitrile in the solvent was evaluated and it was
found that 0.05 M Ringer buffer, 20% acetonitrile
v:v, led to the best improvement of peak defini-
tion and height (Fig. 5). The cyclic voltam-
mogram after accumulation of fluoxetine at 0.8
V shows that acetonitrile protects the electrode
surface by preventing irreversible adsorption of
fluoxetine.
In the presence of acetonitrile, the symmetry of
the differential pulse voltammetric peak also im-
proves and, since the resolution is better, it is
possible to determine lower concentrations of
fluoxetine down to 3.2107M. In these condi-
Fig. 6. Adsorptive stripping voltammograms of a 5.19 mM
fluoxetine solution in 0.05 M Ringer buffer, pH 12, 20%
acetonitrile v:v, tdep5 s at Edep 0.8 V: (1) linear sweep
voltammetry, scan rate 800 mV s1, (2) differential pulse
voltammetry, scan rate 6 mV s1, (3) square wave voltamme-
try, frequency 50 Hz and potential step 6 mV.
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Fig. 7. Square wave adsorptive stripping voltammograms ob-
tained after increasing the fluoxetine concentration in 1.05 mM
steps from 0 (A) to 5.19 mM (F), tdep5 s at Edep 0.8 V.
was determined directly using adsorptive linear
sweep square wave voltammetry method, using
the standard addition method. The results ob-
tained by the electroanalytical method were in
good agreement with those obtained by HPLC
with UV detection using the same samples (Table
1).
4. Conclusions
The reduction of fluoxetine is pH independent
and occurs at very high potentials, which means
that it can be studied only at pH values higher
than 8.5. The use of buffer electrolyte in a mixed
acetonitrile:water solvent proved very convenient
for preventing strong adsorption of the analyte on
the electrode surface and enabling better repro-
ducibility and sensitivity. Adsorptive linear sweep
square wave voltammetry permitted accurate
quantification of fluoxetine in commonly used
pharmaceutical drugs in the micromolar range
after a very simple and rapid sample treatment.
Good precision was obtained (relative standard
deviation2.8%; n10). This electroanalytical
method can be used for determination of thera-
peutic doses of fluoxetine in biological fluids if
coupled with high performance liquid chromatog-
raphy (HPLC) with electrochemical detection.
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In these conditions, a value of 3.9108 M
was determined for the detection limit (defined as
three times the noise). The dependence of peak
current on fluoxetine concentration was found to
be linear over a range from 0.52 to 5.2 mM. Fig.
7 shows square wave voltammograms obtained
after successive standard additions of fluoxetine
chlorhydrate, each addition corresponding to a
1.05 mM increase in concentration. A least-square
treatment of the data in Fig. 7 yields a slope of
14.3 nA M1 and an intercept of 0.42 nA, with a
correlation coefficient of 0.9998. Precision was
calculated by 10 successive measurements of a
5.19 mM fluoxetine solution (accumulation for 5 s
at 0.8 V) with a relative standard deviation of
2.8%.
The fluoxetine content of commercially avail-
able capsules, prepared as described in Section 2,
Table 1
Electrochemical quantification of fluoxetine in pharmacological formulationsa
Sample SWV HPLC
RSD (%)mg:cap Recovery (%) mg:cap RSD (%) Recovery (%)
100320.0A 112623.0
19.6 0.3 101 19.0 4 116B
3C 9820.0 20.0 7 120
D 320.0 102 20.0 2 100
a All formulations refer to 20 mg of fluoxetine per capsule. RSD (%), relative standard deviation.
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